Finance

Beta
Lists
TELO:NASDAQ
Telomir Pharmaceuticals Inc
$1.30
+1.56%
(+0.020) 1D
$1.30
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TELO...
Open
$1.26
High
$1.31
Low
$1.25
Mkt. cap
89.41M
Avg. vol.
188.26K
Volume
128.56K
52-wk high
$3.10
52-wk low
$1.05
EPS
-$0.29
Shares outstanding
68.78M
No. of employees
5
Open
$1.26
High
$1.31
Low
$1.25
Mkt. cap
89.41M
Avg. vol.
188.26K
Volume
128.56K
52-wk high
$3.10
52-wk low
$1.05
EPS
-$0.29
Shares outstanding
68.78M
No. of employees
5
News stories
From sources across the web
About Telomir Pharmaceuticals Inc
CEO-
Employees5
Founded2021
HeadquartersMiami, Florida, United States
SectorPharmaceutical industry
Websitetelomirpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
42.84K
759.52K
1.30M
467.80K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.03M
386.95K
838.47K
573.54K
Operating expense
5.07M
1.15M
2.13M
1.04M
Total operating expenses
5.07M
1.15M
2.13M
1.04M
Operating income
-5.07M
-1.15M
-2.13M
-1.04M
Other non operating income
-
-
-
-
EBT including unusual items
-5.07M
-1.10M
-2.06M
-990.95K
EBT excluding unusual items
-5.07M
-1.10M
-2.06M
-990.95K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.07M
-1.10M
-2.06M
-990.95K
Net profit margin
-
-
-
-
Earnings per share
-0.17
-0.03
-
-
Interest and investment income
1.36K
44.18K
73.49K
51.64K
Interest expense
-1.34K
-
-
-1.26K
Net interest expenses
20.00
44.18K
73.49K
50.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer